Set against the backdrop of a constantly changing and highly regulated environment, the PharmaTimes Marketer of the Year Awards will return to London on the 9th November 2017 to reward the best marketing talent in pharma.
News
Communications Team of the Year open for entry
Healthcare communications continues to evolve and comprises a number of diverse, yet intrinsically linked disciplines, including medical education, PR, policy, public affairs and market access.
NHS could lose more than 2,000 GPs through Brexit
GP leaders are warning that nearly 3.5 million patients are at risk of losing their family doctor, if the status of doctors from the European Union is not protected during Brexit negotiations.
US approves first drug for giant cell arteritis
Roche’s Actemra has become the first drug approved by US regulators specifically to treat giant cell arteritis, a form of vasculitis that results in inflammation of blood vessels.
AZ asthma drug cuts oral steroid use
Patients with severe uncontrolled asthma taking AstraZeneca’s experimental drug benralizumab in a late-stage study either significantly reduced or stopped altogether their intake of oral corticosteroids (OCS), while the drug was also shown to dramatically cut related hospitalisations.
Green light for Sanofi, Regeneron’s Kevzara
Sanofi and Regeneron’s Kevzara has been cleared in the US to treat moderately to severely active rheumatoid arthritis (RA) in adult patients.
UK launch for Ferring’s Rekovelle
Ferring’s novel human recombinant follicle stimulating hormone (human rFSH) Rekovelle has now been launched across the UK for use in controlled ovarian stimulation.
Eleven therapies put forward for EU approval
Eleven new medicines have been put forward for approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use, including new options for a rare eye disease, schizophrenia and cartilage defects.
AZ sells EU rights to Seloken, Logimax to Recordati
AstraZeneca has sold European rights to its metoprolol-containing cardiovascular drugs to Italian drugmaker Recordati for $300 million.
International Clinical Researcher of the Year – Winners announced
The PharmaTimes International Clinical Researcher of the Year Awards took place at the Lancaster London last night, hosted by multi award winning journalist Clive Myrie.
Mixed fortunes continue for Ionis rare disease drug inotersen
Meets its Phase III targets but concerns remain over its side effects profile
Astellas completes 800 million euro biotech acquisition
Belgium’s Ogeda is now a wholly-owned subsidiary of the Japanese pharma firm
Alzheimer’s research seeing ‘exceptionally high levels’ of innovation
Nearly two-thirds of pipeline products have first-in-class potential
Video surveillance could support dementia patients
But consent would be key for the use of home camera-based systems
Bayer lymphoma candidate wins FDA priority review
Regulator backs copanlisib
